• Our People
  • Global Presence
  • Regions
    • Asia
    • Europe
    • Americas
  • Offices
    • Canada
      • Ottawa
      • Toronto
    • China
      • Beijing
      • Hong Kong
    • Luxembourg
    • Malaysia
    • Singapore
    • UK
      • Aberdeen
      • Birmingham
      • Cambridge
      • Edinburgh
      • Glasgow
      • London
      • Manchester
      • Oxford
  • Client liaison
    • Japan
    • Korea
  • Expertise
  • Services
    • Patents
    • Brands & Trade Marks
    • Designs
    • Litigation & Dispute Resolution
    • Commercial IP & Contracts
    • Due Diligence
    • Freedom to Operate
    • EPO Patent Oppositions
    • European Patent Validations
    • Anti-counterfeiting
    • Open Source & Third Party Code
  • Sectors
    • Digital Transformation
      • 3D Printing
      • Artificial Intelligence
      • Blockchain
      • Data & Connectivity
      • Extended Reality
      • Industry 4.0
    • Energy & Environment
    • Life Sciences
    • Agritech
    • Medical Technologies
    • Chemistry
    • Transport
    • Entertainment & Creative Industries
    • Food & Drink
    • Fashion & Retail
    • Universities & Research Bodies
    • Start-ups & Spin-outs
      • Creating value for start-ups
      • The IP driven start-up
    • Financial Services
  • About Us
    • Working with us
    • Awards
    • Corporate & Social Responsibility
    • Diversity & Inclusion
    • Careers
  • Insights
    • Articles
    • News
    • Events
    • Resources
    • Unified Patent Court hub
    • Beyond Brexit: European trade mark hub
    • M&C Reacts
  • Contact Us
Marks & Clerk logo
Marks & Clerk logo
Contact Us
Language
English Français
Our People
Global Presence
Regions
  • Asia
  • Europe
  • Americas
Offices
  • Canada
    • Ottawa
    • Toronto
  • China
    • Beijing
    • Hong Kong
  • Luxembourg
  • Malaysia
  • Singapore
  • UK
    • Aberdeen
    • Birmingham
    • Cambridge
    • Edinburgh
    • Glasgow
    • London
    • Manchester
    • Oxford
Client liaison
  • Japan
  • Korea
Expertise
Services
  • Patents
  • Brands & Trade Marks
  • Designs
  • Litigation & Dispute Resolution
  • Commercial IP & Contracts
  • Due Diligence
  • Freedom to Operate
  • EPO Patent Oppositions
  • European Patent Validations
  • Anti-counterfeiting
  • Open Source & Third Party Code
Sectors
  • Digital Transformation
    • 3D Printing
    • Artificial Intelligence
    • Blockchain
    • Data & Connectivity
    • Extended Reality
    • Industry 4.0
  • Energy & Environment
  • Life Sciences
  • Agritech
  • Medical Technologies
  • Chemistry
  • Transport
  • Entertainment & Creative Industries
  • Food & Drink
  • Fashion & Retail
  • Universities & Research Bodies
  • Start-ups & Spin-outs
    • Creating value for start-ups
    • The IP driven start-up
  • Financial Services
About Us
  • Working with us
  • Awards
  • Corporate & Social Responsibility
  • Diversity & Inclusion
  • Careers
Insights
  • Articles
  • News
  • Events
  • Resources
  • Unified Patent Court hub
  • Beyond Brexit: European trade mark hub
  • M&C Reacts

Patent Term Adjustment in China: Current Status

24 August 2021
Elliot Carrington
Print
Share

On 1 June 2021, the fourth amendment to China’s Patent Law came into effect. One of the potentially important new provisions in this amendment is the Patent Term Adjustment (PTA) scheme. Patent Term Adjustment (PTA) is a mechanism for adding time onto the term of a Patent at the end of its “normal” life. A similar provision has existed in the US for many years, but it is new in China.

To be eligible for PTA, the patent needs to have granted or after 1 June 2021 and been subject to “unreasonable delay” during prosecution. The patent also needs to have been granted more than four years from its filing date and more than three years from the request for substantive examination.

Further, applications for PTA need to be made within 3 months from the date of grant of the patent. The deadline could therefore be as soon as 1 September 2021, i.e. for any patents that granted on 1 June 2021.

Further details of the scheme were released in the draft amendments to the Guidelines for Patent Examination on 3 August 2021. However, these draft Guidelines remain open for public comment until 22 September 2021 and have not yet taken effect. It will therefore take some time for the details of the new provision to become clear, e.g. what will count as “unreasonable delay”, or indeed the length of extension that might be available. It seems that CNIPA are suggesting that patentees may wish to file an application for PTA within the relevant three month period, but no formal consideration of that request will be given until the Guidelines are finalised. While this may leave patentees rather in the dark as to whether a PTA will eventually be granted, we encourage companies with potentially eligible patents, and who tend to keep their Chinese patents in force for the entirety of their term, to consider making use of this new provision.

More details on the effect of the fourth amendment to China’s Patent Law can be found here.

Next Story
  • China’s Amendments to their Patent Law, Implementing Regulations, and Guidelines for Patent Examination
More insights

Latest Insights

Article
- 30 March 2023

That’s a wrap! CJEU confirms position on protection for designs dictated by technical function

"Think about the common sense answer and then it's probably something else!" - that's what I always say to anyone I'm training when they ask me a question about a specific piece of IP law.
Read more
Image: Nike Air Max
Article
- 30 March 2023

Nike block MAX 1 for Verstappen

Max Verstappen's plans to launch a MAX 1 clothing range have run into a roadblock, as Nike successfully oppose his Benelux trade mark application on the basis of their rights in AIR MAX. 
Read more
Chemistry
Article
- 24 March 2023

Preliminary position on priority published

As we reported in early 2022, the Enlarged Board of Appeal of the EPO are considering two pending referrals (G1/22 and G2/22) regarding the question of entitlement to priority. A hearing has now been set for 26 May 2023, and the Enlarged Board have now issued a preliminary opinion setting out the points to be discussed.
Read more
Marks & Clerk logo (white)
  • Terms & Conditions
  • Privacy Notice
  • Cookies
  • Legal Notices
  • Press Enquiries
  • Lexology
  • Mondaq